Patients in Highest Medication Error Risk
Conditions
Brief summary
The purpose of the study is to examine whether a stratified medication review performed in patients at highest risk of experiencing medication errors have impact on numbers of medication errrors during hospitalization.
Detailed description
Acutely admitted medical patients will be included after admission. After inclusion and randomization the patients will be risk stratified with an existing algorithm according to risk of medication error. The patients in the intervention group will receive a medication review performed by a clinical pharmacist if they are in high medication error risk. Patients in highest medication error risk will recieve a medication review performed by a clinical pharmacologist.
Interventions
A mediciation review will be performed in patients with high medication error rik. Patients in the highest risk will receive the medication review from a clinical pharmacologist whereas patients assessed in lesser risk will receive the medication review from a clinical pharmacist.
Sponsors
Study design
Eligibility
Inclusion criteria
* Acutely admitted * \>17 years * Patients being treated with at least one drug at admission
Exclusion criteria
* Dying patients * Suicidal patients * Intoxicated patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Medication errors | During hospitalization ie. between 8 hours and approximately 20 days | Medication errors are defined as errors in prescribing that has the potential to harm patients or actually harm patients. This will be assessed by checking the medical records. Two independent experts will do this. |
Secondary
| Measure | Time frame |
|---|---|
| hospital readmissions (all-cause) | 3 months after discharge |
Countries
Denmark